DIREXION SHS ETF TR's ticker is CURE and the CUSIP is 25459Y876. A total of 20 filers reported holding DIREXION SHS ETF TR in Q4 2022. The put-call ratio across all filers is 0.79 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $52,216 | – | 455 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Traynor Capital Management, Inc. | 13,896 | $928,000 | 0.21% |
| Virtu Financial LLC | 10,420 | $657,000 | 0.11% |
| HRT FINANCIAL LP | 40,123 | $2,529,000 | 0.07% |
| Capital Analysts, LLC | 6,000 | $378,000 | 0.04% |
| Ellis Investment Partners, LLC | 401 | $25,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 3,309 | $209,000 | 0.00% |
| SIGNATUREFD, LLC | 400 | $25,000 | 0.00% |
| JANE STREET GROUP, LLC | 18,800 | $1,185,000 | 0.00% |
| JANE STREET GROUP, LLC | 4,700 | $296,000 | 0.00% |
| UBS Group AG | 4,200 | $265,000 | 0.00% |